Committed to sharing our science

Committed to sharing our science

327 results available

Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial

JAMA Neurology

Shefner, JM et al

March 24, 2025
A Characterization of the Nonclinical Pharmacology and Toxicology of Aficamten, a Reversible Allosteric Inhibitor of Cardiac Myosin

International Journal of Toxicology

Pugsley, MK et al

March 20, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten

Clinical Pharmacokinetics

Xu, D et al

February 5, 2025
Aficamten vs Metoprolol for Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM Rationale, Study Design, and Baseline Characteristics

Journal of the American College of Cardiology: Heart Failure

Garcia-Pavia, P et al

February 3, 2025
Changes in EQ-5D-5L with Aficamten in Obstructive Hypertrophic Cardiomyopathy (oHCM): the SEQUOIA-HCM Trial

Poster, AHA 2024

Schulze, C et al.

November 18, 2024